Feed

Show only
Dr Stephan Werlen, LL.M.
29/05/2019
CMS ad­vises share­hold­ers on the sale of Al­pha Solu­tions...
14/06/2019
The EUIPO de­liv­ers its ver­dict on the long­stand­ing dis­pute between...
EUTM Can­cel­la­tion Ac­tion: (1) Pro­mote Ice­land, (2) The Iceland­ic Min­istry for For­eign Af­fairs and (3) SA – Busi­ness Ice­land v. Ice­land Foods Lim­ited. Back­ground Three Iceland­ic au­thor­it­ies (“Iceland­ic Ap­plic­ants”) filed an ap­plic­a­tion for a de­clar­a­tion of in­valid­ity.
22/05/2019
CMS ad­vises the share­hold­ers on the sale of flu­id­FO­CUS...
11/06/2019
CJEU de­cision tight­ens work­ing time reg­u­la­tions
EU em­ploy­ers must now keep de­tailed re­cords of their em­ploy­ees’ work­ing hours, fol­low­ing a re­cent rul­ing by the Court of Justice of the European Uni­on (CJEU). Na­tion­al law­makers face the chal­lenge of en­sur­ing com­pli­ance across di­verse in­dus­tries and vary­ing.
21/05/2019
CMS ad­vises capiton/Cym­biQ on the ac­quis­i­tion of Koch...
30/05/2019
EPO's strict ap­proach to de­cid­ing if a com­pos­i­tion can be­ne­fit from...
The EPO Tech­nic­al Board of Ap­peal (TBA) re­viewed the law around nov­elty of use, and de­term­ined that in the case of Car­di­oPoly­mer, Inc. 's European pat­ent ap­plic­a­tion (EP07837908. 8), the claimed chem­ic­al en­tity did not qual­i­fy as a 'sub­stance or com­pos­i­tion'.
May 2019
Em­ploy­ment Chal­lenge
Glob­al and grow­ing prac­tice
29/05/2019
Brexit: don't for­get to ne­go­ti­ate the dis­pute res­ol­u­tion clause!
The post­pone­ment of Brexit pro­longs the sus­pense con­cern­ing the fu­ture co­oper­a­tion between the European Uni­on (EU) and the United King­dom (UK). Un­cer­tainty re­gard­ing re­cog­ni­tion and en­force­ment of judg­ments by UK courts in civil and com­mer­cial cases has par­tially.